NCT03584724View on ClinicalTrials.gov

Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

August 20, 2020

Study Completion Date

December 30, 2020

Conditions
Uveitis
Interventions
DRUG

Norflo Oro

Norflo Oro is highly bioavailable curcumin complexed into phytosomes

DRUG

Placebo for Norflo Oro

Placebo consist of look-alike single foil pouches without active ingredient of Norflo.

Trial Locations (1)

33136

Bascom Palmer Eye Institute, Miami

Sponsors

Lead Sponsor

Eye Pharma
All Listed Sponsors
collaborator

Bascom Palmer Eye Institute

OTHER

lead

Eye Pharma

INDUSTRY